Fig. 3.

The expression of miR-103a-2-5p in AML. A miR-103a-2-5p expression in BMMCs of AML patients and healthy donors in our clinical samples. B Kaplan–Meier overall survival curves for 381 patients with AML classified according to relative miR-103a-2-5p expression level. Patients with lower miR-103a-2-5p had shorter survival. C The correlation between miR-103a-2-5p expression and LILRB3 expression was analyzed using Spearman’s rank correlation analysis. All results are presented as the mean ± SD, *P < 0.05, **P < 0.01. Cell experiments were performed three times independently